Open-label, sequential comparison of eptifibatide with abciximab for patients undergoing percutaneous coronary intervention.

Author Department

Medicine

Document Type

Article, Peer-reviewed

Publication Date

1-1-2003

Abstract

BACKGROUND: Platelet glycoprotein IIb/IIIa antagonists reduce complications following percutaneous coronary intervention (PCI). There are limited data comparing different agents. OBJECTIVE: The purpose of this study was to compare in-hospital and 30-day o

Publication ISSN

0149-2918

Share

COinS